When
Where
Oslo Cancer Cluster Innovation Park, Kaare Norum Auditorium
Organizer
You are invited to join the Cell Therapy Innovation Symposium to explore the challenges and innovative solutions in immune cell therapy manufacturing. This symposium will engage experts and professionals involved in the design and manufacturing of immune cell therapies, including process developers, scientist, and lab managers.
A special feature will include a tour of OCC Innovation Park to highlight the recent expansion of this vibrant park anchored by Radium Hospital. The John Ugelstad building is under construction and expected to be completed by the end of 2025. The symposium’s organizing team will track the building progress and if possible, plan a tour (from inside or outside pending approvals).
About the co-organizer: Established in 2021, the CellFit Project is funded by The Research Council of Norway, a project led by Oslo University Hospital with project partners Oslo Cancer Cluster, SINTEF, and Thermo Fisher Scientific. The aim of the project is to improve the fitness of CAR T Cells by optimizing the manufacturing process.
PROGRAM (program with additional speakers will be released by August 15, 2025)
Welcome by Moderators & Co-Chairs
Else Marit Inderberg, PhD, Unit Leader, Translational Research Unit, Section for Cell Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway
&
Tuva Holt Hereng, PhD, Senior Manager R&D Cell Therapy, Oslo, Norway
Speaker
Title: Support functions available at the ACT Centre
Anna Pasetto, Director of the Center for Advanced Cell Therapy (ACT), Section for Cell Therapy, Division for Cancer Treatment, Cancer Clinic, Oslo University Hospital, Associate Professor, Institute of Clinical Medicine, Division of Cancer Medicine, University of Oslo
NOTE about a workshop the next day:
On October 9, 2025, 9am-5pm at OCC Innovation Park: You are invited to register your interest to join a specialized workshop conducted by Thermo Fisher Scientific. Please register your interest with corinna.pohl@thermofisher.com, who will contact you early Q3 2025 about the program.